{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T23:23:54Z","timestamp":1782861834355,"version":"3.54.5"},"reference-count":24,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2013,6,27]],"date-time":"2013-06-27T00:00:00Z","timestamp":1372291200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,7,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Activation of the receptor for advanced glycation endproducts (RAGE) causes sustained activation of multiple inflammatory pathways. Therefore, RAGE has potential as a new therapeutic target in sepsis. The aim of this study was to analyse whether RAGE blockade in vivo prevents microcirculatory dysfunction and subsequent tissue injury in endotoxaemic liver failure.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>The hepatic microcirculation was analysed using intravital fluorescence microscopy in murine livers exposed to galactosamine\/lipopolysaccharide (G\/L) and treated with an anti-RAGE antibody (abRAGE) either 12 h before or 1 h after exposure to G\/L. Blood and liver tissue samples were harvested for analysis of leucocyte tissue infiltration, apoptotic and necrotic damage as well as RAGE downstream pathway signalling.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Sinusoidal perfusion failure in livers exposed to G\/L was reduced significantly by both pretreatment and post-treatment with abRAGE. Hepatic inflammation induced by exposure to G\/L was also attenuated by abRAGE administration, as shown by a 55 per cent reduction in sinusoidal leucocyte stasis, a 65 per cent decrease in venular leucocyte rolling and adhesion, and an 85 per cent reduction in leucocyte tissue infiltration. Treatment with abRAGE markedly reduced hepatocellular apoptosis and necrosis in livers exposed to G\/L, and blunted the rise in plasma high-mobility group protein B1 levels. Finally, G\/L-induced activation of the mitogen-activated protein kinase cascade was also reduced significantly by blockade of RAGE.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>RAGE plays an important role in mediating endotoxaemic liver damage. RAGE blockade may have potential therapeutic value.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1002\/bjs.9188","type":"journal-article","created":{"date-parts":[[2013,6,27]],"date-time":"2013-06-27T09:56:47Z","timestamp":1372327007000},"page":"1229-1239","source":"Crossref","is-referenced-by-count":23,"title":["RAGE blockade and hepatic microcirculation in experimental endotoxaemic liver failure"],"prefix":"10.1093","volume":"100","author":[{"given":"A","family":"Kuhla","sequence":"first","affiliation":[{"name":"Institute for Experimental Surgery, University of Rostock, Rostock, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Norden","sequence":"additional","affiliation":[{"name":"Institute for Experimental Surgery, University of Rostock, Rostock, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Abshagen","sequence":"additional","affiliation":[{"name":"Institute for Experimental Surgery, University of Rostock, Rostock, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M D","family":"Menger","sequence":"additional","affiliation":[{"name":"Institute for Clinical and Experimental Surgery, University of Saarland, Homburg\/Saar, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Vollmar","sequence":"additional","affiliation":[{"name":"Institute for Experimental Surgery, University of Rostock, Rostock, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2013,6,27]]},"reference":[{"key":"2021031616495443600_bjs9188-bib-0001","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1378\/chest.101.6.1644","article-title":"Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP\/SCCM Consensus Conference Committee. American College of Chest Physicians\/Society of Critical Care Medicine","volume":"101","author":"Bone","year":"1992","journal-title":"Chest"},{"key":"2021031616495443600_bjs9188-bib-0002","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1097\/01.CCM.0000261890.41311.E9","article-title":"Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003","volume":"35","author":"Dombrovskiy","year":"2007","journal-title":"Crit Care Med"},{"key":"2021031616495443600_bjs9188-bib-0003","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1177\/0192623311427570","article-title":"Neutrophils and intravascular immunity in the liver during infection and sterile inflammation","volume":"40","author":"McDonald","year":"2012","journal-title":"Toxicol Pathol"},{"key":"2021031616495443600_bjs9188-bib-0004","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1152\/physrev.00027.2008","article-title":"The hepatic microcirculation: mechanistic contributions and therapeutic targets in liver injury and repair","volume":"89","author":"Vollmar","year":"2009","journal-title":"Physiol Rev"},{"key":"2021031616495443600_bjs9188-bib-0005","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/SHK.0b013e31819d8204","article-title":"Prospective assessment of hepatic function and mechanisms of dysfunction in the critically ill","volume":"32","author":"Kortgen","year":"2009","journal-title":"Shock"},{"key":"2021031616495443600_bjs9188-bib-0006","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.cell.2006.02.015","article-title":"Pathogen recognition and innate immunity","volume":"124","author":"Akira","year":"2006","journal-title":"Cell"},{"key":"2021031616495443600_bjs9188-bib-0007","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1038\/39622","article-title":"Lipopolysaccharide-binding protein is required to combat a murine gram-negative bacterial infection","volume":"389","author":"Jack","year":"1997","journal-title":"Nature"},{"key":"2021031616495443600_bjs9188-bib-0008","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4067\/S0716-97602007000200001","article-title":"Toll-like receptors are key participants in innate immune responses","volume":"40","author":"Arancibia","year":"2007","journal-title":"Biol Res"},{"key":"2021031616495443600_bjs9188-bib-0009","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/cc9990","article-title":"The role of receptor for advanced glycation endproducts (RAGE) in infection","volume":"15","author":"van Zoelen","year":"2011","journal-title":"Crit Care"},{"key":"2021031616495443600_bjs9188-bib-0010","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0167-4889(00)00087-2","article-title":"The biology of the receptor for advanced glycation end products and its ligands","volume":"1498","author":"Schmidt","year":"2000","journal-title":"Biochim Biophys Acta"},{"key":"2021031616495443600_bjs9188-bib-0011","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1007\/s00109-005-0688-7","article-title":"Understanding RAGE, the receptor for advanced glycation end products","volume":"83","author":"Bierhaus","year":"2005","journal-title":"J Mol Med (Berl)"},{"key":"2021031616495443600_bjs9188-bib-0012","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1164\/rccm.200707-1069OC","article-title":"Role of soluble receptor for advanced glycation end products on endotoxin-induced lung injury","volume":"178","author":"Zhang","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"2021031616495443600_bjs9188-bib-0013","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1038\/labinvest.2010.84","article-title":"Oxidative stress-associated rise of hepatic protein glycation increases inflammatory liver injury in uncoupling protein-2 deficient mice","volume":"90","author":"Kuhla","year":"2010","journal-title":"Lab Invest"},{"key":"2021031616495443600_bjs9188-bib-0014","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1182\/blood-2009-09-244293","article-title":"RAGE and ICAM-1 cooperate in mediating leukocyte recruitment during acute inflammation in vivo","volume":"116","author":"Frommhold","year":"2010","journal-title":"Blood"},{"key":"2021031616495443600_bjs9188-bib-0015","doi-asserted-by":"crossref","first-page":"G769","DOI":"10.1152\/ajpgi.00275.2003","article-title":"Impact of leukocytes and platelets in mediating hepatocyte apoptosis in a rat model of systemic endotoxemia","volume":"286","author":"Eipel","year":"2004","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"2021031616495443600_bjs9188-bib-0016","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1084\/jem.20040934","article-title":"RAGE limits regeneration after massive liver injury by coordinated suppression of TNF-alpha and NF-kappaB","volume":"201","author":"Cataldegirmen","year":"2005","journal-title":"J Exp Med"},{"key":"2021031616495443600_bjs9188-bib-0017","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/sj.bjp.0707230","article-title":"Antileukoproteinase protects against hepatic inflammation, but not apoptosis in the response of d-galactosamine-sensitized mice to lipopolysaccharide","volume":"151","author":"Eipel","year":"2007","journal-title":"Br J Pharmacol"},{"key":"2021031616495443600_bjs9188-bib-0018","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1373\/clinchem.2008.112797","article-title":"The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments","volume":"55","author":"Bustin","year":"2009","journal-title":"Clin Chem"},{"key":"2021031616495443600_bjs9188-bib-0019","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1172\/JCI200418704","article-title":"Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response","volume":"113","author":"Liliensiek","year":"2004","journal-title":"J Clin Invest"},{"key":"2021031616495443600_bjs9188-bib-0020","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/hep.20045","article-title":"Blockade of receptor for advanced glycation end product (RAGE) attenuates ischemia and reperfusion injury to the liver in mice","volume":"39","author":"Zeng","year":"2004","journal-title":"Hepatology"},{"key":"2021031616495443600_bjs9188-bib-0021","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1161\/hc0702.104183","article-title":"Advanced glycation end products activate endothelium through signal-transduction receptor RAGE: a mechanism for amplification of inflammatory responses","volume":"105","author":"Basta","year":"2002","journal-title":"Circulation"},{"key":"2021031616495443600_bjs9188-bib-0022","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S1097-2765(00)80136-7","article-title":"MyD88 is an adaptor protein in the hToll\/IL-1 receptor family signaling pathways","volume":"2","author":"Medzhitov","year":"1998","journal-title":"Mol Cell"},{"key":"2021031616495443600_bjs9188-bib-0023","first-page":"351","article-title":"RAGE on the Toll Road?","volume":"3","author":"Lin","year":"2006","journal-title":"Cell Mol Immunol"},{"key":"2021031616495443600_bjs9188-bib-0024","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.4049\/jimmunol.1002253","article-title":"Septic shock is associated with receptor for advanced glycation end products ligation of LPS","volume":"186","author":"Yamamoto","year":"2011","journal-title":"J Immunol"}],"container-title":["British Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fbjs.9188","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/bjs\/article-pdf\/100\/9\/1229\/36618643\/bjs9188.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/bjs\/article-pdf\/100\/9\/1229\/36618643\/bjs9188.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T14:09:24Z","timestamp":1621519764000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjs\/article\/100\/9\/1229-1239\/6138432"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,27]]},"references-count":24,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2013,6,27]]},"published-print":{"date-parts":[[2013,7,10]]}},"URL":"https:\/\/doi.org\/10.1002\/bjs.9188","relation":{},"ISSN":["0007-1323","1365-2168"],"issn-type":[{"value":"0007-1323","type":"print"},{"value":"1365-2168","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2013,8]]},"published":{"date-parts":[[2013,6,27]]}}}